Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-17-014775

President and CEO sold 9,562 shares at an average $17.22 ($164,658)

  • President and CEO acquired 9,562 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
McCarthy Sean A. President and CEO 2017-04-03 Option exercise +4,781 $0.95 $4,518 6,760 D: show line 1 in the form
McCarthy Sean A. President and CEO 2017-04-03 Sale −4,781 $16.94 $80,990 1,979 D: show line 2 in the form
McCarthy Sean A. President and CEO 2017-04-04 Option exercise +4,781 $0.95 $4,518 6,760 D: show line 3 in the form
McCarthy Sean A. President and CEO 2017-04-04 Sale −4,781 $17.50 $83,668 1,979 D: show line 4 in the form
Open-market sales · 9,562 sh · avg $17.22 · $164,658

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
McCarthy Sean A. President and CEO 2017-04-03 Option exercise · Stock Option (right to buy) −4,781 77,634 D: show line 5 in the form
McCarthy Sean A. President and CEO 2017-04-04 Option exercise · Stock Option (right to buy) −4,781 72,853 D: show line 6 in the form
Loading xslF345X03/doc1.xml…